Leonard Schleifer Biography
Leonard Schleifer is a well-known American businessman, co-founder, and chief executive of the biotechnology company Regeneron Pharmaceuticals.
Schleifer’s impact on the field of biotechnology and pharmaceuticals is profound. Regeneron, under Schleifer’s leadership, has developed several successful drugs that have transformed the lives of patients around the world. One of the company’s most notable achievements is the development of Eylea, a treatment for age-related macular degeneration that has improved the vision of millions of patients.
The reader should care about Leonard Schleifer because of his impact on society. The drugs developed by Regeneron have improved the lives of millions of people, and the company’s continued success in developing new treatments has the potential to benefit countless others. Schleifer’s leadership and vision have also created jobs and stimulated economic growth in the biotech industry, which has a ripple effect on society as a whole.
10 Quick Facts About Leonard Schleifer
- Name: Leonard Schleifer
- Age: 70 Years (2023)
- Birthday: To be Updated
- Zodiac Sign: To be Updated
- Height: Average
- Nationality: American
- Occupation: Businessman and Chief Executive
- Marital Status: Married
- Salary: $1,767,800
- Net worth: $ 2.3 billion
Leonard Schleifer Age
Leonard Schleifer is 70 years old as of 2023. He was born in 1953 in Queens, New York, United States. His birthday is publicly not available. We will update this section once this information is available.
Leonard Schleifer Height
Schleifer stands at an average height He appears to be quite tall in stature if his photos, relative to his surroundings, are anything to go by. However, details regarding his actual height are currently not publicly available. We are keeping tabs and will update this information once it is out.
Leonard Schleifer Weight
Schleifer has a moderate weight. His weight is publicly not available. We will update this section once the information is available.
Leonard Schleifer Early Life and Education
Schleifer was born and raised in a Jewish family, the son of Charles Baker Schleifer, and Florence Schleifer, in Queens, New York. His father was a World War II codebreaker and a sweater manufacturer.
However, he graduated with a B.S. from Cornell University and an MD-PhD from the University of Virginia where he studied under future Nobel Laureate, Alfred G. Gilman. He thereafter worked at New York Hospital where he trained to become a neurologist and also acted as a junior faculty member.
Leonard Schleifer Rise to Fame
Schleifer rose to fame after co-founding Regeneron Pharmaceuticals, Inc., a biotech company that specializes in developing innovative medicines for serious medical conditions. He is widely recognized as one of the most successful and significant figures in the pharmaceutical industry.
Schleifer joined the faculty of Cornell Medical College and became inquisitive in the development of new treatments for neurological disorders. In the early 1980s, he founded the pharmaceutical company Neurogenetics to develop drugs to treat Alzheimer’s disease and other neurological conditions which made him rise to fame.
In 1988, Schleifer founded Regeneron with scientist George Yancopoulos, who had worked with him at Neurogenetics. The company’s initial focus was on developing treatments for nerve growth factor, which plays a key role in the growth and survival of nerve cells.
Regeneron had several setbacks in its early years, including the failure of its nerve growth factor drugs in clinical trials. However, the company persevered and eventually shifted its focus to the development of monoclonal antibody drugs, which are highly targeted therapies that can be used to treat a wide range of diseases.
Regeneron’s breakthrough came in 2011 when the company’s drug Eylea was approved by the FDA for the treatment of age-related macular degeneration, a leading cause of blindness in the elderly. Eylea quickly became a blockbuster drug, generating billions of dollars in revenue for Regeneron.
Leonard Schleifer Parents
Schleifer was born in Queens, New York, United States as the son of Florence Schleifer(mother) and Charles Baker Schleifer (father) who was a sweater manufacturer and World War II codebreaker.
Leonard Schleifer Siblings
Any information about Schleifer children is publicly not available. It is not known if he has children. We will update this section once the information is available.
Leonard Schleifer Wife
Schleifer is currently married to his lovely wife Harriet Partel Schleifer who serves as a member of the Board of Governors of the American Jewish Committee and as president of her synagogue. The couple together is the proud parents of two children; Adam and David. His son Adam was one of many candidates for the nomination in the 2020 Democratic Primary for New York’s 17th congressional district.
Leonard Schleifer Children
Schleifer together with his wife are proud parents of two children; Adam and David.
Leonard Schleifer Salary
Schleifer receives an average annual salary of $1,767,800. This is Per our average wage estimates for a Businessman and Chief Executive in the United States. However, these figures may vary substantially according to the level of seniority of the employee.
Leonard Schleifer Net Worth
Schleifer has an estimated net worth of $ 2.3 billion USD as of 2023. This includes his assets, money, and income. His primary source of income is his career as a Businessman and Chief Executive. Through his various sources of income, Schleifer has been able to accumulate good fortune but prefers to lead a modest lifestyle.
Leonard Schleifer Measurements and Facts
Here are some interesting facts and body measurements you should know about Leonard.
Leonard Schleifer Wiki
- Full Names: Leonard S. Schleifer
- Popular As: Leonard Schleifer
- Gender: Male
- Occupation / Profession: Businessman and Chief Executive
- Nationality: American
- Race / Ethnicity: White
- Religion: Jewish
- Sexual Orientation: Straight
Leonard Schleifer Birthday
- Age / How Old?: 70 Years (2023)
- Zodiac Sign: To be Updated
- Date of Birth: 1953
- Place of Birth: Queens, New York, United States
- Birthday: To be Updated
Leonard Schleifer Body Measurements
- Body Measurements: To be Updated
- Height / How Tall?: Average
- Weight: Moderate
- Eye Color: Brown
- Hair Color: Brown
- Shoe Size: To be Updated
- Chest Size: To be Updated
- Waist Size: To be Updated
Leonard Schleifer Family and Relationship
- Father (Dad): Charles Baker Schleifer
- Mother: Florence Schacht Schleifer
- Siblings (Brothers and Sisters): To be Updated
- Marital Status: Married
- Spouse/Wife: Married to Harriet Partel Schleifer
- Dating/Girlfriend: Not Applicable
- Children: Adam Schleifer and David Schleifer
Leonard Schleifer Networth and Salary
- Net Worth: $ 2.3 billion
- Salary: $1,767,800
- Source of Income: Businessman and Chief Executive
Leonard Schleifer Early Career Experiences
Schleifer earned his undergraduate degree from Cornell University and then went on to earn an MD and Ph.D. in pharmacology from the University of Virginia. After finishing his education, Schleifer started a residency in neurology at the Weill Cornell Medical Center in New York City.
Schleifer’s first job in the pharmaceutical industry was as a senior vice president at the pharmaceutical company Bristol-Myers Squibb, where he performed on the development of a drug to treat Alzheimer’s disease.
In 1988, he left Bristol-Myers Squibb to found his own company, which he named Regeneron Pharmaceuticals. The company focused on developing new drugs using genetically-engineered mice. It has been highly successful under Schleifer’s leadership. The company has developed a number of successful drugs, including Eylea, which is used to treat age-related macular degeneration, and Dupixent, which is used to treat asthma and eczema.
Schleifer and his wife have been active philanthropists, donating millions of dollars to medical research and education. They have made large donations to Cornell University, the University of Virginia, and Weill Cornell Medical Center.
Leonard Schleifer Regeneron
Schleifer is the co-founder and CEO of Regeneron Pharmaceuticals, a leading biotechnology company based in Tarrytown, New York. Schleifer co-founded Regeneron in 1988 with scientist George Yancopoulos and venture capitalist Robert Terifay.
Under Schleifer’s leadership, Regeneron has become a major player in the biotech industry, with a focus on developing innovative therapies for a range of diseases, including cancer, cardiovascular disease, and inflammatory diseases. The company has achieved significant success with its blockbuster drug Eylea, which is used to treat age-related macular degeneration, a leading cause of blindness in the elderly.
Regardless, he is known for his focus on scientific innovation and for fostering a culture of collaboration and entrepreneurship within Regeneron. He has been recognized for his contributions to the biotech industry with numerous awards, including the Ernst & Young Entrepreneur of the Year Award in Healthcare and the Biotechnology Industry Organization’s Biotech Humanitarian Award.
Leonard Schleifer Compensation
In 2020, Schleifer’s total compensation was reported to be $28.3 million, which included a base salary of $1.5 million, a cash bonus of $3.6 million, and stock awards worth $23.2 million. The stock awards were tied to Regeneron’s performance, as the company’s share price increased by more than 60% in 2020.
Also, his compensation has been a topic of controversy, with some investors and critics arguing that it is excessive, especially given the high prices of Regeneron’s drugs. However, supporters of Schleifer’s compensation argue that it reflects his leadership and the company’s success in developing innovative medicines and delivering value to shareholders.
It is worth noting that Schleifer has been with Regeneron since its inception in 1988 and has played a key role in the company’s growth and success. He holds a medical degree and a Ph.D. in pharmacology from the University of Virginia, and prior to founding Regeneron, he worked at the investment bank Donaldson, Lufkin & Jenrette.
Leonard Schleifer Accomplishments
- Schleifer founded Regeneron Pharmaceuticals in 1988, and the company has become one of the most successful biotechnology firms in the world. The company has developed a number of successful drugs, including Eylea and Dupixent.
- Eylea, which was approved by the FDA in 2011, is a drug used to treat age-related macular degeneration, a common cause of blindness in older adults. The drug has been highly successful, generating billions of dollars in revenue for Regeneron.
- Dupixent, which was approved by the FDA in 2017, is a drug used to treat asthma and eczema. Like Eylea, Dupixent has been highly successful, generating billions of dollars in revenue for Regeneron.
- Schleifer has been at the forefront of many important scientific discoveries, particularly in the field of genetic engineering. He was one of the first scientists to use genetically-engineered mice to develop new drugs, a strategy that has since become widespread in the pharmaceutical industry.
- Schleifer and his wife have been generous philanthropists, donating millions of dollars to medical research and education. They have made large donations to Cornell University, the University of Virginia, and Weill Cornell Medical Center.
- Schleifer has acquired numerous awards and honors for his work in the pharmaceutical industry, including the Ernst & Young Entrepreneur of the Year Award and the Warren Alpert Foundation Prize.
Leonard Schleifer Future Aspirations and Goals
Schleifer remains committed to the development of new drugs and treatments that can improve the lives of patients suffering from serious illnesses. Regeneron is currently working on a number of new treatments for conditions such as cancer, rheumatoid arthritis, and Alzheimer’s disease.
Schleifer has emphasized the importance of collaboration in the pharmaceutical industry, and he has sought out partnerships with other companies and researchers to help accelerate the development of new treatments.
Schleifer and his wife have been active philanthropists, and he has expressed a desire to continue supporting medical research and education. He has also been vocal about the need for the pharmaceutical industry to do more to make drugs more affordable and accessible to patients in need.
In recent years, Regeneron has expanded its operations beyond its headquarters in New York State. Schleifer has expressed a desire to continue expanding the company’s footprint, both domestically and internationally.
He has been a prominent figure in the pharmaceutical industry for many years, and he has played a key role in shaping the direction of the industry. He will likely continue to be a thought leader and advocate for innovation and patient-centered care in the years to come.
Leonard Schleifer Legacy
Schleifer’s success as an entrepreneur and his commitment to improving the lives of patients have inspired many others in the pharmaceutical industry and beyond. His legacy will continue to inspire future generations of medical professionals and entrepreneurs to make a difference in the world.
Leonard Schleifer Anecdotes
As a young medical student, Schleifer was inspired by a professor who urged him to think beyond the textbook and to approach medicine with a sense of curiosity and creativity. This experience helped to shape his approach to medicine and research later in life.
Schleifer has been known to take risks and think outside the box when it comes to drug development. For example, he once approved a clinical trial for a drug that had been rejected by other companies, even though it seemed like a long shot. The drug turned out to be successful and is now one of Regeneron’s top products.
Schleifer is known for his sense of humor and his ability to make his employees feel valued and appreciated. He once dressed up as Elvis Presley for a company party, and he has been known to personally call and thank employees for their hard work.
Schleifer was one of the first scientists to use genetically-engineered mice to develop new drugs, but he didn’t have much experience working with animals at the time. In fact, he accidentally killed the first genetically-engineered mouse that he worked with, but he didn’t give up. He kept working at it and eventually became a pioneer in the field.
Leonard Schleifer Quotes
Leonard Schleifer Hobbies and interests:
- Hobbies: Running, biking, and playing tennis
- Passions: Improving the lives of patients through innovative drug development
- Interests: Intersection of science, medicine, and business
Frequently Asked Questions About Leonard Schleifer
Leonard Schleifer is a well-known American businessman, co-founder, and chief executive of the biotechnology company Regeneron Pharmaceuticals.
Schleifer is an American national born in 1953 in Queens, New York, United States. His birthday is publicly not available. We will update this section once this information is available.
Schleifer stands at an average height, he has not shared his height with the public. His height will be listed once we have it from a credible source.
Schleifer is currently married to his lovely wife Harriet Partel Schleifer who serves as a member of the Board of Governors of the American Jewish Committee and as president of her synagogue.
Schleifer has an approximate net worth of $ 2.3 billion. This amount has been accrued from her leading roles in the business industry.
Schleifer receives an average annual salary of $1,767,800.
Schleifer is a resident of Chappaqua, New York, USA, we shall upload pictures of his house as soon as we have them.
Schleifer is alive and in good health. There have been no reports of him being sick or having any health-related issues.
Schleifer is currently the founder, president, and chief executive officer of Regeneron Pharmaceuticals.
Leonard Schleifer Contacts
- Youtube
- Tiktok
- Website
Related Biographies.
You may also like to read the Bio, Career, Family, Relationship, Body measurements, Net worth, Achievements, and more about:
- Dr. Arturo Casadevall
- Dr. Calvin Sun
- Dr. William Robinson
- Dr. Elvis Francois
- Scott Borgerson
- Michael O’Leary
- Ajay Banga
- John C Miller
About InformationCradle Editorial Staff
This Article is produced by InformationCradle Editorial Staff which is a team of expert writers and editors led by Josphat Gachie and trusted by millions of readers worldwide.
We endeavor to keep our content True, Accurate, Correct, Original and Up to Date. For complain, correction or an update, please send us an email to informationcradle@gmail.com. We promise to take corrective measures to the best of our abilities.